SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-20-000043
Filing Date
2020-10-30
Accepted
2020-10-30 16:13:31
Documents
79
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20200930.htm   iXBRL 10-Q 1932841
2 EX-10.1 a2020q310-qexhibit101.htm EX-10.1 1564277
3 EX-31.1 a2020q310-qexhibit311.htm EX-31.1 10783
4 EX-31.2 a2020q310-qexhibit312.htm EX-31.2 10781
5 EX-32.1 a2020q310-qexhibit321.htm EX-32.1 6773
11 vrtx-20200930_g1.jpg GRAPHIC 26316
12 vrtx-20200930_g2.jpg GRAPHIC 35932
  Complete submission text file 0000875320-20-000043.txt   10394609

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20200930.xsd EX-101.SCH 44653
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20200930_cal.xml EX-101.CAL 94606
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20200930_def.xml EX-101.DEF 287369
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20200930_lab.xml EX-101.LAB 596324
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20200930_pre.xml EX-101.PRE 413786
13 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20200930_htm.xml XML 1731349
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 201277490
SIC: 2834 Pharmaceutical Preparations